Performant Healthcare, Inc.
PHLTNASDAQTechnology
$7.75
+$0.02(+0.26%)
Market Cap$611643477
P/E Ratio—
52W High$7.76
52W Low$2.17
Performant Healthcare, Inc. (PHLT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PHLT · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 5, 2025EPS Actual
-$0.03
Est. -$0.02 · -50.0%
Revenue
—
Est. $0.03B
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 5, 2025
After Market Close
▼ Miss EPS
PHLT reports quarterly as a NASDAQ-listed Information Technology Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.46
Rev. $3.65B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.46
Rev. Est.$3.65B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 6, 2026 | -$0.01 | — | — | — | $0.03B | — |
| ◌ Q1 FY2026 | Mar 10, 2026 | $0.02 | — | — | — | $0.04B | — |
| ▼ Q4 FY2025 | Nov 5, 2025 | -$0.02 | -$0.03 | -50.0% | — | $0.03B | — |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.03 | $0.03 | +200.0% | $0.04B | $0.03B | +21.5% |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.02 | $0.02 | +200.0% | $0.03B | $0.03B | +5.9% |
| ▲ Q1 FY2025 | Mar 12, 2025 | -$0.02 | $0.02 | +200.0% | $0.03B | $0.03B | +19.3% |
| — Q4 FY2024 | Nov 6, 2024 | -$0.03 | -$0.03 | +0.0% | $0.03B | $0.03B | -0.2% |
| ▲ Q3 FY2024 | Aug 7, 2024 | -$0.05 | -$0.04 | +20.0% | $0.03B | $0.03B | +4.2% |
Q2 FY2026
May 6, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 10, 2026
EPS Actual
—
EPS Est.
$0.02
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 5, 2025Miss
EPS Actual
-$0.03
EPS Est.
-$0.02
EPS Surpr.
-50.0%
Revenue
—
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$0.03
EPS Est.
-$0.03
EPS Surpr.
+200.0%
Revenue
$0.04B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$0.02
EPS Est.
-$0.02
EPS Surpr.
+200.0%
Revenue
$0.03B
Q1 FY2025
Mar 12, 2025Beat
EPS Actual
$0.02
EPS Est.
-$0.02
EPS Surpr.
+200.0%
Revenue
$0.03B
Q4 FY2024
Nov 6, 2024
EPS Actual
-$0.03
EPS Est.
-$0.03
EPS Surpr.
+0.0%
Revenue
$0.03B
Q3 FY2024
Aug 7, 2024Beat
EPS Actual
-$0.04
EPS Est.
-$0.05
EPS Surpr.
+20.0%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.07 | $0.07 | $0.07 | 1 |
| Q3 FY2026 | $0.04 | $0.04 | $0.04 | 1 |
| Q2 FY2026 | $0.02 | $0.02 | $0.02 | 1 |
| Q1 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2025 | $0.02 | $0.02 | $0.02 | 2 |
| Q3 FY2025 | $-0.00 | $-0.00 | $-0.00 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2025 | Nov 5, 2025 | -50.0% | $7.75 | — | — |
| ▲ Q3 FY2025 | Aug 7, 2025 | +200.0% | $7.62 | $7.63 | +0.13% |
| ▲ Q2 FY2025 | May 8, 2025 | +200.0% | $2.28 | $2.25 | -1.32% |
| ▲ Q1 FY2025 | Mar 12, 2025 | +200.0% | $2.52 | $2.52 | +0.00% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +0.0% | No price data | $3.16 | — |
| ▲ Q3 FY2024 | Aug 7, 2024 | +20.0% | No price data | $3.16 | — |
| ▲ Q1 FY2024 | Mar 31, 2024 | +13.0% | No price data | $3.16 | — |
| ▼ Q4 FY2023 | Dec 31, 2023 | -18.9% | No price data | $3.16 | — |
Q4 FY2025—
Report Date
Nov 5, 2025
EPS Beat/Miss
-50.0%
Price Before
$7.75
Price After
—
Q3 FY2025+0.13%
Report Date
Aug 7, 2025
EPS Beat/Miss
+200.0%
Price Before
$7.62
Price After
$7.63
Q2 FY2025-1.32%
Report Date
May 8, 2025
EPS Beat/Miss
+200.0%
Price Before
$2.28
Price After
$2.25
Q1 FY2025+0.00%
Report Date
Mar 12, 2025
EPS Beat/Miss
+200.0%
Price Before
$2.52
Price After
$2.52
Q4 FY2024—
Report Date
Nov 6, 2024
EPS Beat/Miss
+0.0%
Price Before
—
Price After
$3.16
Q3 FY2024—
Report Date
Aug 7, 2024
EPS Beat/Miss
+20.0%
Price Before
—
Price After
$3.16
Q1 FY2024—
Report Date
Mar 31, 2024
EPS Beat/Miss
+13.0%
Price Before
—
Price After
$3.16
Q4 FY2023—
Report Date
Dec 31, 2023
EPS Beat/Miss
-18.9%
Price Before
—
Price After
$3.16
Avg Beat Reaction-0.40%
Beat Rate6 / 8 quarters
Largest Move-1.32% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PHLT ends December
Performant Healthcare, Inc. (PHLT) most recently reported earnings on November 5, 2025 for Q4 FY2025, posting EPS of $-0.03 — missing the analyst consensus of $-0.02 by -50.0%. The next PHLT earnings date is expected around September 1, 2026.
Each quarter, investors track PHLT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PHLT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PHLT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PHLT earnings · 5 questionsPerformant Healthcare, Inc.'s next earnings report is expected around September 1, 2026. PHLT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PHLT historically reports after market close (AMC).
PHLT earnings datewhen is PHLT earningsPHLT next earnings datewhen does PHLT report earningsPHLT earnings calendar
▸ Source: FMP · Performant Healthcare, Inc. SEC filings · US GAAP · Performant Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026